Tissue and reaction studies
Whole blood and liver tissue were used to examine spatial reaction behavior and the apparent boundary of the contact zone.
Investigator’s Brochure v1.0 §§4.1–4.2, Figures 4-1 and 4-3–4-5SunGlow Innovations
The experimental and observational record behind the clinical development plan.
Whole blood and liver tissue were used to examine spatial reaction behavior and the apparent boundary of the contact zone.
Investigator’s Brochure v1.0 §§4.1–4.2, Figures 4-1 and 4-3–4-5Mouse observations evaluated route-specific effects, including local vascular injury.
Investigator’s Brochure v1.0 §§4.1, 4.3, Figures 4-2, 4-7 and 4-8The investigator brochure summarizes 22 animals with spontaneous tumors: 19 dogs and 3 cats. Clinical signs and local tissue changes varied by case.
Investigator’s Brochure v1.0 §5, Figures 5-1–5-5 · IND Module 2.5, Table 6-1Historical records cover approximately 25 patients. Available documentation describes local tissue changes and both local and serious adverse events.
Investigator’s Brochure v1.0 §§6.1–6.3, Table 6-1 and Figures 6-1–6-6 · IND Module 2.5, Tables 3-1 and 4-1Historical observations describe ultrasound and CT visualization of delivery distribution. The Phase 1 plan evaluates containment separately from follow-up non-viability.
Investigator’s Brochure v1.0 §§2.3, 4.2 and 7.3, Figure 4-6 · Protocol v3.0 §§3, 7 and 10.3The clinical plan combines adverse-event surveillance with assays for reaction products and hematologic markers.
Investigator’s Brochure v1.0 §§4.4, 6.3, 7.7 and 8 · Protocol v3.0 §§8–9 · 2026-11-19Proposed assessments cover safety, containment, local activity and durability.
Protocol v3.0 §§3–5, 9 and 10 · 2026-11-19